Filing Details
- Accession Number:
- 0001209191-18-023720
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-04 16:47:30
- Reporting Period:
- 2018-04-02
- Accepted Time:
- 2018-04-04 16:47:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578696 | David Davidson | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-04-02 | 22,000 | $24.47 | 46,905 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-04-02 | 955 | $162.77 | 45,950 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-02 | 2,900 | $163.86 | 43,050 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-02 | 2,375 | $164.66 | 40,675 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-02 | 1,518 | $166.18 | 39,157 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-02 | 3,400 | $167.21 | 35,757 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-02 | 1,900 | $168.09 | 33,857 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-02 | 3,800 | $169.36 | 30,057 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-02 | 3,552 | $170.55 | 26,505 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-02 | 1,600 | $171.33 | 24,905 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-04-02 | 22,000 | $0.00 | 22,000 | $24.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 43,000 | 2024-03-03 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017.
- The range in prices for the transaction reported on this line was $162.30 to $163.20. The average weighted price was $162.7703. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $163.35 to $164.30. The average weighted price was $163.8623. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $164.35 to $165.10. The average weighted price was $164.6629. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $165.75 to $166.70. The average weighted price was $166.1827. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $166.75 to $167.55. The average weighted price was $167.2144. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $167.85 to $168.80. The average weighted price was $168.0921. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $168.90 to $169.85. The average weighted price was $169.3559. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $170.05 to $171.00. The average weighted price was $170.5544. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $171.05 to $171.60. The average weighted price was $171.3343. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period, at a rate of twenty-five percent(25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
